1. Home
  2. Quan, Jianchao

Quan, Jianchao

Quan, Jianchao, Clinical Assistant Professor, Division of Health Economics, Policy and Management, BA (Oxon), BM BCh (Oxon), MA (Oxon), MEcon (HK), MPH (HK), MD (HK), FHKCCM, FHKAM (Community Medicine), phone: 3917 9909, email: jquan@hku.hk
Clinical Assistant Professor

Division of Health Economics, Policy and Management

  • BA (Oxon), BM BCh (Oxon), MA (Oxon), MEcon (HK), MPH (HK), MD (HK), FHKCCM, FHKAM (Community Medicine)
phone 3917 9909
email jquan@hku.hk
scholarsHub http://hub.hku.hk/cris/rp/rp02266
pub med PubMed
orcid ORCID: Quan, Jianchao
Biography

Prof Chao Quan earned his bachelor’s (BA) and medical degrees (BM BCh) at the University of Oxford (UK). He did his housemanship training at the London Foundation School (UK). He completed master’s degrees in public health (MPH) and economics (MEcon) and a higher doctorate in research (MD) at the University of Hong Kong. Prof Quan is a Clinical Specialist in Public Health Medicine, a Fellow of the Hong Kong College of Community Medicine, and a Fellow of the Hong Kong Academy of Medicine. He is also Warden of Wei Lun Hall.

His research focuses on health policy, healthcare services, and health economics. His research has been published in the top journals in the fields of health policy, health services, and healthcare sciences: Health Affairs, PLOS Medicine, BMC Medicine, Lancet Public Health, Lancet Regional Health - Western Pacific, European Journal of Health Economics and Value in Health. He has presented at major international conferences including International Health Economics Association (IHEA), International Society for Quality in Health Care (ISQua), Health Systems Global (HSG), BMJ International Forum on Quality and Safety in Healthcare, and American Public Health Association (APHA).

As Principal Investigator, he has been awarded over 13 projects totalling over HK$52 million (US$6.6 million), including 4 competitive GRF/ECS grants from the Research Grants Council. His research has been commissioned by the Department of Health and the Health Bureau, Government of Hong Kong SAR, and presented to current and previous Secretary for Health. His work on the economic costs of tobacco has been cited in policy briefings to the Hong Kong Legislative Council for the passage of the Tobacco Control Legislation (Amendment) Bill 2025. He has collaborated with the China Center for Disease Control and Prevention (China CDC) to model the health and economic impact of diabetes across China and is currently advising China CDC on the econometric modelling of alcohol control policies.

Dr Quan has served as an expert advisor to the World Health Organization and is a member of the Hong Kong Government Steering Committee on Health Accounts (health financing). He also serves on the Hong Kong Academy of Medicine Governing Council for Young Fellows. He was a visiting researcher at Stanford University (USA) and London School of Hygiene and Tropical Medicine (UK), and honorary clinical fellow at University College London Hospital (UK).

Dr Quan oversees admissions and curriculum development for the Master of Public Health programme (Health Economics, Policy and Management concentration). He also Chairs the Staff-Student consultative committee. Dr Quan has led many quasi-experimental policy analyses including the earliest impact studies of strengthening road safety policies to counteract alcohol tax deregulation and extending statutory paid maternity leave to improve maternal mental health. His expertise in microsimulation led to the development of the first externally validated lifetime simulation model for diabetes in East Asia.

Please contact Prof Quan with a resume for research opportunities: jquan@hku.hk.

Current projects:

  • discrete choice experiments in health insurance
  • international comparison of attributable disease-related healthcare expenditure
  • health economic evaluation of screening and public health genomics
  • economics of caregiving and evaluation of district-based caregiver support

Selected Publications
  1. Xiong X, Huo ZH, Zhou Y, Bishai DM, Grépin KA, Clarke PM, Chen CH, Luo L, Quan J*. Economic Costs Attributable to Modifiable Risk Factors: An analysis of 2.2 million hospitalizations in an urban area of China. BMC Medicine. 2024 Nov 21. https://doi.org/10.1186/s12916-024-03772-7
    IF: 8.3 (2024), Rank: 19/332 Medicine, General & Internal
  2. Ng CS, Yu WSC, Leung L, Wong EK, Ho SYD, Ip DKM, Wu Y, Wang MP, Quan J*. Economic costs of tobacco-related diseases in Hong Kong in 2021. Tobacco Control. 2024 Nov 28. https://doi.org/10.1136/tc-2024-058817
    IF: 4.7 (2024), Rank: 4/58 Substance Abuse; 34/419 Public, Environmental and Occupational Health
  3. Andres EB, Du X, Pang SSL, Liang JN, Ye J, Lee MH, Tarrant M, Yung SS, Johnston JM, Lok KYW, Quan J*. Extended paid maternity leave associated with improved maternal mental health in Hong Kong. Health Affairs. 2024 May 6. https://doi.org/10.1377/hlthaff.2023.00742
    IF 9.7 (2022), Rank 1/87 Health Policy & Services; 2/106 Health Care Sciences & Services
  4. Quan J, Zhao Z, Wang L, Ng CS, Kwok HHY, Zhang M, Zhou S, Ye J, Ong XJ, Ma R, Leung GM, Eggleston K, Zhou M. Potential health and economic impact associated with achieving risk factor control in Chinese adults with diabetes: a microsimulation modelling study. The Lancet Regional Health – Western Pacific. 2023 Apr 1. https://doi.org/10.1016/j.lanwpc.2023.100690
    IF 8.6 (2021), Rank 3/109 Health Sciences & Services; Rank 10/182 Public, Environmental and Occupational Health
  5. Ng CS, Au M, Ma R, Leung JYY, Quan J*. The impact of alcohol pricing policies on public health in Hong Kong, China: a modelling study. The Lancet Regional Health – Western Pacific. 2022 Sep 1. https://doi.org/10.1016/j.lanwpc.2022.100510
    IF 8.6 (2021), Rank 3/109 Health Sciences & Services; Rank 10/182 Public, Environmental and Occupational Health
  6. Ng CS, Au M, Leung JYY, Leung GM, Tian L, Quan J*. The impact of road safety policies in a deregulated alcohol tax environment in Hong Kong: a 15-year time series analysis. Addiction. 2022 Mar 8. https://doi.org/10.1111/add.15866
    IF 7.3 (2021), Rank 3/37 Substance Abuse
  7. Quan J, Ng CS, Kwok HHY, Zhang A, Yuen YH, Choi CH, Siu SC, Tang SY, Wat NM, Woo J, Eggleston K, Leung GM. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modelling study. PLOS Medicine. 2021 Jun 24. https://doi.org/10.1371/journal.pmed.1003692
    IF 11.1 (2020), Rank 10/169 Medicine, General & Internal
  8. Mok CH, Kwok HHY, Ng CS, Leung GM, Quan J*. Health state utility values for type 2 diabetes and related complications in East and Southeast Asia: a systematic review and meta-analysis. Value in Health. 2021 Apr 10. https://doi.org/10.1016/j.jval.2020.12.019
    IF 5.7 (2020), Rank 4/88 Health Policy & Services, 9/108 Health Sciences & Services, 24/377 Economics
  9. Quan J, Pang D, Li TK, Choi CH, Siu SC, Tang SY, Wat NM, Woo J, Lau ZY, Tan KB, Leung GM. Risk Prediction Scores for Mortality, Cerebrovascular, and Heart Disease Among Chinese People with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2019 Dec 1. https://doi.org/10.1210/jc.2019-00731
    IF 5.6 (2018), Rank 22/145, Endocrinology & Metabolism
  10. Quan J, Zhang H, Pang D, Chen BK, Johnston JM, Jian W, Lau ZY, Iizuka T, Leung GM, Fang H, Tan KB, Eggleston K. Avoidable hospital admissions from diabetes complications in Japan, Singapore, Hong Kong, and communities outside Beijing. Health Affairs. 2017 Nov 1. https://doi.org/10.1377/hlthaff.2017.0479
    IF 5.7 (2018), Rank 3/81 Health Policy & Services, 3/98 Health Care Sciences & Services


Back